Actively Recruiting
A Study of Clinician Satisfaction and Likelihood of Clinical Adoption of the VERABAND174; Wearable Activity Monitor for Chronic Low Back Pain
Led by University of Michigan · Updated on 2026-06-03
360
Participants Needed
3
Research Sites
26 weeks
Total Duration
On this page
Sponsors
U
University of Michigan
Lead Sponsor
N
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating clinician satisfaction and the likelihood of clinical adoption of the VERABAND174; a newly developed, disposable, wearable activity monitor designed for people with chronic low back pain (cLBP). This study involves multiple clinical sites and aims to assess how useful and user-friendly the VERABAND system is for managing cLBP, regardless of the specific pain treatments used. The study is conducted under an approved institutional review board protocol with an estimated 340 patient participants and 20 clinicians across tertiary pain clinics. Participants diagnosed with cLBP who are ambulatory and beginning a new non-surgical pain treatment will receive a VERABAND activity monitor during their initial clinic visit. The monitor continuously tracks activity until the patient's next clinic visit, and weekly summary reports from the device will be provided to their treating clinicians before follow-up visits. Clinicians will complete a survey measuring their satisfaction with the VERABAND's usability and its potential usefulness for different patient profiles at the end of each patient's care episode. During the study, patient participants are monitored longitudinally through their normal care visits while wearing the VERABAND device. Researchers will collect clinician feedback using the System Usability Scale over approximately seven weeks to measure satisfaction and adoption likelihood. The study focuses on how well the device supports clinical management of cLBP and explores whether it is more helpful for patients with varying pain levels or psychological characteristics. The total study duration extends up to the follow-up visit after starting new treatments.
CONDITIONS
Brief Title
Clinician Satisfaction With the VERABAND™
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ambulatory
- Diagnosis of chronic low back pain according to NIH Task Force criteria
- Low back pain that interferes with mobility
- Starting a new non-surgical treatment or combination of treatments for chronic low back pain
- Willing to wear the VERABAND174; continuously until next clinic visit and return used devices by mail
- Age between 18 and 85 years
You will not qualify if you...
- Signs of ongoing systemic disease such as fever, weight loss, pain after major trauma, immunosuppression, recent infection, or severe sensory/motor problems
- Inability to speak and write English
- Visual or hearing difficulties that prevent participation
- Severe psychiatric disorders, including active suicidal thoughts or history of suicide attempts
- Receiving disability or compensation or involved in litigation
- Scheduled surgery before follow-up visit
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 7 weeks
Participants receive a VERABAND™ activity monitor during an initial clinic visit and begin a new pain treatment regimen as part of their normal ongoing care while wearing the device continuously.
Baseline visit and follow-up clinic visits
Duration - Approximately 7 weeks
Participants continue to be tracked longitudinally while clinicians receive weekly activity data reports from the VERABAND™ device prior to each follow-up clinic visit to support clinical management.
Weekly visits for up to 7 weeks
Trial Site Locations
Total: 3 locations
1
Altman Clinical and Translational Research Institute
La Jolla, California, United States, 92037
Not Yet Recruiting
2
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
Actively Recruiting
3
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
K
Kristi Pickup, MSW
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here